As previously reported, Wells Fargo analyst Timothy Daley upgraded Agilent to Overweight from Equal Weight with a price target of $170, up from $150. The analyst reiterates a negative Pharma/Biotech outlook on late-cycle headwinds and positive Industrial/Applied outlook on secular growth tailwinds, expecting both themes to continue playing out in the first half of 2023 as the cycle rotation from peak to trough bottoms and secular growth tailwinds further materialize, respectively. He sees increasingly mixed signals from Academic/Govt as budding growth catalysts are offset by rapidly increasing political risk.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on A:
- Agilent upgraded to Overweight from Equal Weight at Wells Fargo
- Agilent authorizes $2B buyback authorization
- Agilent invests $725M for manufacturing of therapeutic nucleic acids
- Gordon Haskett wonders if Guardant could be ‘shoehorned’ into Agilent search
- Agilent, Akoya to develop diagnostic solutions for tissue analysis